What is the recommended dosing and administration of Ferrex‑150 (polysaccharide‑iron complex) for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ferrex-150 Dosing for Iron Deficiency Anemia

Ferrex-150 (polysaccharide-iron complex) should be dosed at 150 mg of elemental iron once daily in adults, which is the standard formulation strength for this product. 1

Adult Dosing

  • Standard dose: 150 mg elemental iron once daily 1
  • Alternative regimen for symptomatic patients: Up to 200 mg elemental iron daily, divided into 2-3 doses, though this exceeds the single Ferrex-150 capsule strength 1
  • Optimal absorption: Administer on an empty stomach without food or other medications to maximize intestinal iron uptake 1

Pediatric Dosing

  • Weight-based dosing: 2-3 mg/kg/day of elemental iron in children 1
  • Polysaccharide-iron complex formulations are available but specific pediatric safety data for Ferrex-150 are limited in FDA labeling 1

Duration of Therapy

  • Treatment course: Continue oral iron for 3-12 weeks to correct anemia and replenish iron stores 2
  • Monitoring interval: Reassess hemoglobin and iron parameters at 4-8 weeks to evaluate response 3

Cost Considerations

  • Monthly cost: Approximately $7.12 for 150 mg elemental iron daily, making polysaccharide-iron complex more expensive than ferrous sulfate ($2.29/month) or ferrous fumarate ($1.63/month) 1
  • Despite higher cost, polysaccharide-iron complex may offer better gastrointestinal tolerability in selected patients 1

When Oral Iron Fails

  • Inadequate response threshold: If hemoglobin fails to increase by 1-2 g/dL within 4-8 weeks, consider switching to intravenous iron 3
  • Indications for IV iron: Intolerance to oral iron, malabsorption disorders, active inflammatory bowel disease, need for rapid correction (hemoglobin <10 g/dL), or chronic kidney disease 4
  • Preferred IV formulations: Ferric carboxymaltose (750-1000 mg per dose) or ferric derisomaltose (1000-1500 mg single dose) allow complete repletion in 1-2 visits versus 8 weekly visits required for ferric gluconate 5, 3

Common Pitfalls to Avoid

  • Do not combine oral and IV iron: Concurrent use increases side effects without additional benefit 5
  • Do not dose more frequently than once daily: Recent evidence shows once-daily dosing (or even alternate-day dosing) is as effective as multiple daily doses while reducing gastrointestinal side effects 6
  • Do not continue indefinitely without monitoring: Check complete blood count and iron studies at 4-8 weeks to assess response and avoid iron overload 3
  • Do not expect immediate results: Hemoglobin typically begins rising within 1-2 weeks but full correction requires 4-8 weeks 3

Absorption Considerations

  • Reduced absorption with food: Concurrent food intake significantly impairs iron absorption 1
  • Drug interactions: Separate administration from calcium supplements, antacids, proton pump inhibitors, and tetracycline antibiotics by at least 2 hours 1
  • Hepcidin effect: In patients with chronic inflammation or chronic kidney disease receiving erythropoiesis-stimulating agents, oral iron absorption may be severely limited despite adequate dosing 1

References

Research

Oral and Intravenous Iron Therapy.

Advances in experimental medicine and biology, 2025

Guideline

Iron Deficiency Anemia Treatment with Ferric Derisomaltose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Iron Deficiency Anemia Treatment with Ferric Derisomaltose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ferric Gluconate Dosing for Severe Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Iron supplementation in iron deficiency anaemia].

Nederlands tijdschrift voor geneeskunde, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.